Home > Press > New Nanomaterial for regenerative medicines at SMi’s Pharmaceutical Nanotechnology conference
Abstract:
Nanotechnology is a multidisciplinary scientific field that is currently undergoing explosive development. Nano-enhanced medicines are opening new opportunities for therapeutic delivery and targeting technology
New Nanomaterial for regenerative medicines at SMi’s Pharmaceutical Nanotechnology conference
London, UK | Posted on March 27th, 2011Join SMi at their inaugural case study driven conference that will address not only the latest scientific developments, but also the know-how required to successfully translate these discoveries and technologies into a commercially successful product.
Come and hear key presentations from the top 50 pharma companies that include:
The business case for nanotechnology
Thomas Keller, Director, Open Innovation, GlaxoSmithKline
Miniaturisation and modelling of beads milling
Mostafa Nakach, Head of Pharmaceutical Engineering Group, Sanofi-Aventis R&D
Investigation of chitosan nanoparticle formulations
Michael Keller, Senior Fellow, siRNA Project Leader, Technical Research and Development (TRD), Novartis Pharma
Enabling oncology drug development with nanotechnology
Henry Havel, Senior Research Fellow, Product Research and Development, Eli Lilly and company
Industry partnering opportunities, open innovation, one solution
Peter Luke, Senior Director, R&D Business Development, Worldwide Business Development, Pfizer
####
About SMi
Pharmaceutical Nanotechnology: Applications & Commercialisation is just one of the many conferences that are a part of the SMi Group portfolio.
The SMi Group is a world leader in business to business information. With nearly two decades in the business, thousands of senior executives from blue chip companies have already benefitted from SMi’s highly targeted conferences, workshops and publications. For more information visit www.smi-online.co.uk
For more information, please click here
Contacts:
Zain Philbey
+44 0 207 827 6722
Copyright © SMi
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
| Related News Press |
News and information
Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025
Next-generation quantum communication October 3rd, 2025
"Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Announcements
Rice membrane extracts lithium from brines with greater speed, less waste October 3rd, 2025
Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025
Next-generation quantum communication October 3rd, 2025
"Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025
Events/Classes
Institute for Nanoscience hosts annual proposal planning meeting May 16th, 2025
A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024
Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||